Ovoca Bio Share Discussion Threads

[blakesmith] 28/5/2024 14:36

Banked profit at 1.28

[citys2874] 28/5/2024 14:32

may even get a TR-1 tomorrow

[citys2874] 28/5/2024 13:51

number 4 on the leaderboard risers great to see

[citys2874] 28/5/2024 13:38

multi-bagger at this price just the beginning of the rise up great time to be in

[citys2874] 28/5/2024 13:33

Leonid Skoptsov loading up shares

[citys2874] 28/5/2024 13:32

volume crossed 7.8 million

[citys2874] 28/5/2024 13:19

up 60 percent

[citys2874] 28/5/2024 13:17

up 52 percent mms ticking up

[citys2874] 28/5/2024 13:12

up 40 percent rising strong now

[citys2874] 28/5/2024 13:11

in the top 5 risers now moving up

[citys2874] 28/5/2024 13:10

buys trippling sells primed to breakout this afternoon

[citys2874] 28/5/2024 13:09

2.00+ incoming

[the codger] 25/4/2024 05:50

Good markup yesterday.cash in hand still worth more than market value.

[mdi] 13/4/2024 14:15

Any sign of them launching the placebo spray from the failed drug study as a medical device ‘clinically proven’ to work. Just like Futura medical has done

[mdi] 01/3/2024 14:32

hTtps://www.proactiveinvestors.co.uk/companies/news/946551/how-futura-medical-turned-med3000-into-a-near-billion-pound-opportunity-946551.htmlWhy haven't OVB turned the placebo nasal spray from their failed study into a similar 'near billion pound opportunity'?

[mdi] 01/3/2024 12:20

Why don’t Ovoca Bio just copy the Futura Medical strategy and seek to get the placebo spray from their failed study just approved as a ‘clinically proven’ medical device spray? Its worked for FUM on paper .



Futura have a market Cap of over £119m from generating less then £4m in sales from marketing their placebo as ‘clinically proven’.

[jimtech] 02/2/2024 11:10

As I had difficulty asking questions at the OVB AGM I sent some later by email.

Here are their responses which might be of interest.

Bear in mind I received their email below on 4th December so it is a couple of months old:

[JT 2] Clearly the recent Australian / New Zealand Orenetide trial results were extremely disappointing. It would seem to me that there has either been a flaw in previous trials or in this recent one. Which one is it?
[OVB] We strongly disagree that the disappointing results of a recent study mean that there is a flaw in this or the previous studies. Clinical studies are very complex scientific process with risks and uncertain outcome, despite any previous results. This was disclosed in Ovoca’s Re-Admission Document for the Proposed Acquisition of IVIX (Part 2 “Risk factors”, “RISKS RELATING TO THE ENLARGED GROUP AND THE SECTOR IN WHICH IT OPERATES” at p. 19-20):
“…Clinical testing is expensive and can take many years to complete and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process… The results of … earlier clinical trials may not be predictive of the results of later stage clinical trials. For example, the results generated to date in … Phase I or Phase II clinical trials for the Enlarged Group’s product candidate does not ensure that later clinical trials will demonstrate similar results. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through pre-clinical studies and initial clinical trials…”
Unfortunately, it seems that this scientific risk has been realized.

[JT 3] Who oversaw the previous Russian Orenetide (BP-101) trials? Was it the management of IVIX?
[OVB] The previous Russian Orenetide (BP-101) trials were administrated by one of the leading Russian Contract Research Organizations (CRO) – OCT Clinical Trials. Trials Sponsor oversight (which is mandatory according to ICH GCP standard on clinical trials) was done by the management of IVIX. This is public information, but disclosed in the Russian clinical trials registry (however we have checked – automated page translation into English is available in the Chrome browser, and we assume it should be available in other major browsers).
Also, public information is available in the Clinicaltrials.gov registry: hxxps://www.clinicaltrials.gov/study/NCT03463707.

[JT 4] Is there any future at all for Orenentide?
[OVB] For the moment we are not ready to make any conclusions – study report is still in process, and additional internal assessments are ongoing. The Company will determine the appropriate future strategy regarding the development of Orenetide, including whether the Company can and should continue with its development of this product.

[JT 5] What is the future strategy for Ovoca Bio now?
[OVB] Again, we are assessing the Orenetide trial results and any implications this may have for the wider strategy of the Company, including a number of potential strategies. We will keep shareholders informed on any developments as and when appropriate. Please keep in mind that while answering to this question we are limited by AIM rules on disclosure of material and insider information, so our reply may not contain any significant comments / material updates beyond anything that already has been published via RNS.

[dave4545] 23/1/2024 07:44

Great you finally get a RNS and it's a pointless holding RNS from months ago.

[dave4545] 21/1/2024 11:09

Almost 5 months and not a word from the company. Would have thought this was plenty of time to decide if to stick or twist with orenetide.

[luckyabbeygale] 08/1/2024 08:59

This is only just the start.
Covid stocks are now all the rage again.

[luckyabbeygale] 04/1/2024 23:08

It is okay to invest this way when one has a lot of spare money for other stocks.

My biggest regret today was not selling some of my non moving shares to invest into Angel first thing at 17p.

However I managed to buy £4,000 worth and most likely they be worth more than double tomorrow.

I do have a very good feeling about this Ovoca and it is going to take some time, but it will be worth it in the end.

[dave4545] 04/1/2024 11:45

You paid all time low my style of investing.

Even if they give up on Orenetide there is still a very attractive cash shell route here and they still have Russian assets wether or not they can extract any money from them remains a long shot but they could take a hit and get something for them

[luckyabbeygale] 04/1/2024 11:04

Wow I am going to take it. As this seems to good an opportunity to miss.

I am in for 142277 at 0.84p.

[dave4545] 04/1/2024 08:20

3 months now not a peep, surely by now they must know wether to stick or twist.

0.85p offer online, absolutely dead now which you can expect.